Company Overview and News

Chinese Tycoon Flips 007 Casino for All-in Bet on Korean Island - Bloomberg

21h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Chinese tycoon flips 007 casino for all-in bet on South Korean island

2018-04-16 bworldonline
Soon after property tycoon Yang Zhihui bet his fortune on luring Chinese gamblers and investors to a giant casino resort project in South Korea, his ambitions were threatened by an economic war that flared up between the two nations. Yang not only weathered the political spat over North Korea’s nuclear program, but his massive project expanded and his company announced this month it would build another casino in the Philippines.
Upvote Downvote

Genting plans to bid for Japan gaming licence

PETALING JAYA: Genting Bhd is optimistic that the Japan Integrated Resort Execution Bill will be tabled in this year’s Diet session, paving the way for the group to formally bid for its Japan gaming licence.
Upvote Downvote

Japan Casino Law Picks Up Steam: Las Vegas Sands, Leading Candidate, Could Get Knock On Effect Very Soon

2018-03-29 seekingalpha
LVS will invest up to $10bn on a property we think could generate over $5billion in GGR if they win Osaka.
Upvote Downvote

Stocks To Watch: Back To Basics Time

2018-03-10 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Upvote Downvote

Singapore Budget 2018: Winners and losers

2018-02-19 themalaymailonline
Singapore Budget 2018 aims to financially equip the city state for financial pressures that will come with a rapidly aging population. — Reuters file pic SINGAPORE, Feb 19 — A range of tax increases, including a 2 percentage point increase to 9 per cent in the goods and services levy, were unveiled by Singapore Finance Minister Heng Swee Keat in his budget speech to Parliament as among measures to financially equip the city state for financial pressures that will come with a rapidly aging population.
Upvote Downvote

Malaysia’s top 40 richest people

LAST year was dotted by the return of higher commodity prices and better economic growth. The world’s economies on average are back in business as growth rates and trade have started to improve once again after some period of uncertainty caused by a cooling China economy and also the slump in global crude oil prices.
Upvote Downvote

Fitch says ending Genting Singapore coverage

2018-02-02 themalaymailonline
Chinese tourists arrive at the lobby of Genting Singapore's Resorts World Sentosa casino in Singapore in this April 29, 2013 file photo. — Reuters picKUALA LUMPUR, Feb 2 — Fitch Ratings said it will no longer rate Genting Singapore PLC staring in March over unstated “commercial reasons.”
Upvote Downvote

Genting getslucky again

The diversified conglomerate, whose business covers casinos; leisure and entertainment; plantation; power; as well as oil and gas, is seeing improving prospects across most of its divisions, especially gaming, thanks to increasingly positive market conditions.
Upvote Downvote

Fitch sees Genting reaping higher earnings from leisure and plantation sectors

n its rating announcement yesterday Fitch pointed out Resorts World Genting has opened several new facilities as part of its 10-year RM10bil redevelopment masterplan launched in 2013.
Upvote Downvote

SE Asia stocks rise on bargain hunting as US-Korea tensions ease

2017-08-14 themalaymailonline
An electronic board shows the Korea Composite Stock Price Index (KOSPI) at a bank in Seoul June 27, 2013. — Reuters picSINGAPORE, Aug 14 — South-east Asian stock markets closed higher today as investors picked up beaten down shares, looking past tensions between the United States and North Korea.
Upvote Downvote

International Moat Index: France Impacted Its Performance

2017-05-31 marketrealist
French aerospace firm Safran SA (SAF FP, +10.52%) edged out London Stock Exchange Group Plc (LSE LN, +10.38%) as the top International Moat Index performer in April. SAF FP also saw its fair value estimate increased by Morningstar analysts at the end of the month. The top sector performers for the month came from real estate and industrials firms. Several Hong Kong property firms helped boost the real estate sector including Swire Properties Ltd.
Upvote Downvote

Maybank IB: Plenty of catalysts for Genting

Sky Plaza contribution: The SkyWay cable car at Genting resort. The Sky Plaza is expected to contribute from quarter two in FY2017.
Upvote Downvote

Edward Farrell Appointed President Of Resorts World Las Vegas

2017-05-17 prnewswire
Gaming Industry Veteran to Develop and Operate Las Vegas' First Ground-Up Resort in Nearly a Decade Multibillion-Dollar Integrated Resort Slated to Open in 2020 with Full Construction Commencing in Q3 2017
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 37251T104